Imaging of human papilloma virus associated oropharyngeal squamous cell carcinoma and its impact on diagnosis, prognostication, and response assessment

P Touska, S Connor - The British Journal of Radiology, 2022 - academic.oup.com
The clinical behaviour and outcomes of patients with oropharyngeal cancer (OPC) may be
dichotomised according to their association with human papilloma virus (HPV) infection …

Potential successes and challenges of targeted cancer therapies

DMK Keefe, EH Bateman - JNCI Monographs, 2019 - academic.oup.com
The concept and realization of targeted anticancer therapy (TAT) have existed for at least
two decades and continue to expand rapidly. It has become clear that there is no “magic …

[HTML][HTML] Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma

W Gong, Y Xiao, Z Wei, Y Yuan, M Qiu, C Sun, X Zeng… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Precision medicine is a new strategy that aims at preventing and treating human diseases
by focusing on individual variations in people's genes, environment and lifestyle. Precision …

Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab

AABA da Costa, F D'Almeida Costa, AR Ribeiro… - International journal of …, 2015 - Springer
Background Platinum-based chemotherapy associated with cetuximab is the first-line
treatment for inoperable recurrence or metastatic head and neck squamous cell carcinoma …

[HTML][HTML] Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes

MR Jubran, D Vilenski, E Flashner-Abramson… - Theranostics, 2022 - ncbi.nlm.nih.gov
Therapeutic strategies for advanced head and neck squamous carcinoma (HNSCC) consist
of multimodal treatment, including Epidermal Growth Factor Receptor (EGFR) inhibition …

The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma

AABA da Costa, FDA Costa, DV Araújo… - Medical oncology, 2019 - Springer
There is no established biomarker for cetuximab efficacy in recurrent head and neck
squamous cell carcinoma (HNSCC). The aim of the present study was to evaluate the …

Predictive value of pAKT/PTEN expression in oral squamous cell carcinoma treated with cetuximab-based chemotherapy

J Lyu, H Song, Z Tian, Y Miao, G Ren, W Guo - Oral surgery, oral medicine …, 2016 - Elsevier
Objective Molecular alterations in downstream effectors of epidermal growth factor receptor
may confer resistance to epidermal growth factor receptor inhibitors. Our aim is to investigate …

Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell …

L de Souza Viana, FC de Aguiar Silva… - Head & …, 2016 - Wiley Online Library
Background The purpose of this phase II trial was to evaluate the tolerability, safety, and
efficacy of a non–5‐fluorouracil (5‐FU)‐based induction chemotherapy followed by …

Identification of somatic gene mutations in penile squamous cell carcinoma

C Ferrándiz‐Pulido, J Hernández‐Losa… - Genes …, 2015 - Wiley Online Library
There is a lack of studies on somatic gene mutations and cell signaling driving penile
carcinogenesis. Our objective was to analyze somatic mutations in genes downstream of …

Does nodal metastasis and perineural invasion affect local control in hyalinizing clear cell carcinoma of the oral cavity? A case report with long term follow-up

JM Le, D Gubarev, Y Ying, A Morlandt - Head and Neck Pathology, 2021 - Springer
Hyalinizing clear cell carcinoma (HCCC) is a rare, low-grade neoplasm accounting for
approximately 1% of salivary gland neoplasms. Histologically, it is characterized by a …